Scientists develop first drug-like compounds to inhibit elusive cancer-linked enzymes

Monday, August 31, 2020 - 16:00 in Biology & Nature

Structural biology techniques helped researchers target the nuclear receptor-binding SET domain family for the first time; its malfunction is associated with several types of cancer.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net